Lelypharma
Updating the operating model
- Pharmaceuticals
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Lelypharma's published strategy and is not endorsed by, or produced in cooperation with, Lelypharma. Company website
Strategic priorities
Lelypharma operates across 4 stated priorities, with the most concrete near-term plan anchored on dutch standard quality.
Maintaining the highest pharmaceutical standard through meticulous verification of every batch against sacred production protocols, serving as the foundation of customer trust in the human and veterinary medicine supply chain.
Enabling flexibility to accept very small quantities with no minimum order through efficient changeover processes and multi-product cleanroom capabilities, differentiating from large-scale global competitors.
Providing immediate insight into documentation, certificates, and stability study results through the My Lelypharma portal, establishing trust through accessibility and service responsiveness.
-
01
Dutch Standard Quality
Maintaining the highest pharmaceutical standard through meticulous verification of every batch against sacred production protocols, serving as the foundation of customer trust in the human and veterinary medicine supply chain.
-
02
Operational Agility
Enabling flexibility to accept very small quantities with no minimum order through efficient changeover processes and multi-product cleanroom capabilities, differentiating from large-scale global competitors.
-
03
Customer Transparency
Providing immediate insight into documentation, certificates, and stability study results through the My Lelypharma portal, establishing trust through accessibility and service responsiveness.
-
04
ESG Compliance
Meeting group-level CSRD sustainability requirements and reducing CO2 footprint across energy-intensive cleanroom operations, aligning with EU regulatory frameworks for pharmaceutical manufacturers.
Challenges we see
- Operations Manufacturing
Labor-Intensive Machine Changeovers
Every product requires unique machine and cleanroom settings, and the production team acknowledges that switching from one task to another remains "very labor-intensive" despite facility upgrades. This limits the number of customers Lelypharma can serve within existing capacity.
Manual changeover processes create a revenue ceiling tied directly to headcount and floor hours, preventing the scalability required to achieve stated growth goals of helping more customers in the same amount of time.
- Digital Integration
Document-Centric Quality Management
The production protocol is described as a "sacred document" requiring manual signature and verification, while the My Lelypharma customer portal functions primarily as a document repository rather than real-time monitoring platform.
Paper-based or static digital records create a trust deficit between shop floor and data scientists, requiring manual transcription into registration files and increasing the risk of non-contemporaneous documentation violations flagged by FDA and EMA.
- Digital Operations
Siloed Laboratory Data
The 11-person QC laboratory operates with high skill but no integrated Laboratory Information Management System connecting directly to manufacturing PLC systems, creating disconnected data islands within the Lelystad facility.
Manual lab data management creates bottlenecks for the quick delivery times Lelypharma promises, elongating time-to-market for new customer products and preventing real-time biological KPI visualization.
- ESG Energy
Energy-Intensive Environmental Control
The penicillin cleanroom requires constant humidity control below 20%, adjusted manually "at the push of a button" without predictive or automated environmental sequencing based on production schedules.
Without IoT-driven smart HVAC systems, energy costs exceed necessary levels while tracking Scope 1, 2, and 3 emissions for CSRD compliance becomes administratively burdensome without automated sensors.
- Operations Manufacturing
Tribal Knowledge Dependencies
Production leadership describes "cracking difficult production cases" through veteran employee expertise, with the "trick" to making tablet production feasible residing in individual experience rather than standardized digital processes.
Critical process knowledge is not scalable during labor shortages or staff turnover, and reliance on manual adjustment of machines for high-sensitivity mixing of potent substances creates vulnerability to human fatigue and variability.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
Real-Time Process Monitoring Gap
The My Lelypharma customer portal provides documentation retrospectively but customers cannot see live telemetry of stability studies or production environments, limiting transparency to historical outcomes rather than active process intelligence.
Upgrade the customer portal to a TechBio platform with real-time stability test telemetry, automated validation status, and live KPI dashboards, transforming passive document retrieval into active process partnership.
-
Changeover Automation Deficit
Production changeovers between different products and cleanroom configurations remain labor-intensive manual processes, creating a direct bottleneck between production capacity and the goal of serving more customers in the same time.
Implement MTP (Module Type Package) modular retrofitting to transform changeovers into Plug & Produce events, enabling automated orchestration of machine settings and cleanroom parameters based on product recipes.
-
Lab-to-Production Data Silos
The QC laboratory manages stability studies and raw material checks manually without an integrated LIMS connecting to manufacturing systems, preventing real-time biological KPI visualization and Golden Batch comparison capabilities.
Implement Lab Digitalization with an Industrial Data Platform connecting laboratory instruments to production systems, enabling automated data capture, real-time analytics, and elimination of manual Excel workflows.
-
Manual Batch Documentation Risk
As Qualified Person, batch release depends on manual audit of the "sacred protocol" for every batch, creating regulatory risk for data integrity violations related to non-contemporaneous documentation and inadequate cleaning validation.
Implement Electronic Batch Records with automated audit trails, moving from retrospective inspection to proactive quality assurance with real-time verification of analyst training, instrument calibration, and process parameters.
-
Cleanroom Energy Optimization
The penicillin cleanroom requires strict humidity control below 20% with manual adjustment between different environmental settings, without predictive HVAC management based on production schedules or IoT energy monitoring.
Implement IT/OT convergence with IoT sensors and smart HVAC systems to optimize energy usage based on real-time machine activity and production schedules, while generating automated CSRD emissions reporting.
What we'd propose
- Digital CDMO
Real-Time Customer Intelligence Portal
Transform the My Lelypharma document repository into a TechBio customer workspace with live stability test telemetry, automated validation status dashboards, and real-time project visibility enabling proactive customer partnership.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
MTP-Based Changeover Automation
Retrofit legacy tableting and packaging equipment with Module Type Package compliant interfaces enabling Plug & Produce changeovers, automated recipe management, and orchestration-layer integration for multi-product scheduling.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Integrated Laboratory Execution System
Deploy a Laboratory Execution System connecting QC instruments to manufacturing systems through secure OT gateways, enabling automated data capture, LIMS integration, and elimination of manual transcription workflows.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Electronic Batch Record Platform
Implement GxP-compliant Electronic Batch Records replacing paper-based production protocols with digital workflows, automated audit trails, and real-time verification of compliance prerequisites.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Smart Cleanroom Energy Management
Deploy IoT sensor networks and intelligent HVAC control systems in cleanroom environments to optimize energy consumption based on production schedules while generating automated sustainability reporting.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what Lelypharma's own published ambition implies — not a perfect score.
- Process Automation 35 → 75
- Barcode-controlled weighing exists but changeovers and batch documentation remain largely manual with labor-intensive machine adjustments
- Data Integration 25 → 80
- Siloed data islands between QC lab, production floor, and customer portal with no unified LIMS-to-PLC connectivity
- Real-Time Analytics 20 → 70
- Customer portal provides document retrieval only; no live telemetry, Golden Batch overlays, or predictive process intelligence
- Regulatory Technology 40 → 85
- Paper-based sacred protocols create data integrity risk; manual documentation for international market registrations
- IoT Infrastructure 30 → 75
- Modern machinery exists but lacks connected sensors for predictive maintenance, energy monitoring, or automated environmental control
- Knowledge Digitization 25 → 70
- Critical production expertise resides in veteran employees as tribal knowledge rather than captured in digital recipes or decision support systems
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Electronic Batch Record (eBR) Readiness
Check how far your batch records are from paperless, and what the next step is.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Market comparison
European CDMOs Compared
The 2026 landscape: who does what, at what scale.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
Think we've read this right?
Talk to usRelated reading
-
Accelerating lab and manufacturing operations with MTP – a modular approach
Among the various modular and plug-n-produce approaches, the Modular Type Package (MTP) approach has emerged as a game-changer.
-
From Paper to Performance: Operational Efficiency and Compliance in Labs
Transform your QC lab with scalable digital solutions that embed compliance, boost efficiency, and deliver a future-ready competitive edge.
-
Still biotech or already techbio?
The results of a Tech Imperatives for biotech 2022 report indicate changes in biotech production and management.
-
Developing a data and technology-driven flexible lab operations model
Now, when it becomes clear to the biotech companies that only by sharing the data they can thrive, everyone is looking for a solution.
-
Addressing sustainability in pharma & biotech
At A4BEE, we combine company social responsibility and sustainability needs with the path set by the company’s values and mission.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Lelypharma, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].